Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Assets (2016 - 2021)

Historic Return on Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Q3 2021 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Assets fell 100.0% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.03% for FY2019, which is 100.0% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Return on Assets stood at 0.05%, which was down 100.0% from 0.01% recorded in Q2 2021.
  • Neurocrine Biosciences' Return on Assets' 5-year high stood at 0.14% during Q2 2020, with a 5-year trough of 0.61% in Q1 2017.
  • Over the past 5 years, Neurocrine Biosciences' median Return on Assets value was 0.02% (recorded in 2019), while the average stood at 0.06%.
  • As far as peak fluctuations go, Neurocrine Biosciences' Return on Assets crashed by -3800bps in 2017, and later skyrocketed by 4800bps in 2018.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Return on Assets stood at 0.18% in 2017, then surged by 112bps to 0.02% in 2018, then surged by 31bps to 0.03% in 2019, then rose by 23bps to 0.04% in 2020, then skyrocketed by 33bps to 0.05% in 2021.
  • Its Return on Assets was 0.05% in Q3 2021, compared to 0.01% in Q2 2021 and 0.03% in Q1 2021.